| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2021 12-31 |
|---|---|---|---|
| Report Filing | 2025-11-06 | 2025-03-20 | 2022-03-31 |
| Revenue | 61.6 | 25.38 | 0 |
| Cost of Revenue | 4.22 | 1.62 | 0 |
| Gross Profit | 57.38 | 23.77 | 0 |
| Operating Expenses | -14.42 | 200.6 | 226.8 |
| Research & Development | 120.8 | 137.3 | 182.9 |
| Selling, General and Administrative | 56.43 | 63.39 | 36.52 |
| Other Operating Expenses | -191.7 | 0 | 7.38 |
| Operating Income | 71.8 | -176.9 | -226.8 |
| Net Non-Operating Interest | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 |
| Equity & Other Income/(Expense) | 8.54 | 6.95 | 0 |
| Income Before Tax | 80.33 | -169.9 | -226.8 |
| Income Tax Expense | -0.832 | 0 | 0 |
| Income Attributable to Non-Controlling Interest | 0.832 | 0 | 0 |
| Net Income | 80.33 | -169.9 | -226.8 |
| Depreciation and Amortization | 0.016 | 0 | 1.43 |
| EBITDA | 71.81 | -176.9 | -225.4 |
| Earnings Per Share (EPS) | 1.93 | -1.43 | -2.04 |
| Diluted Earnings Per Share | 1.93 | -1.43 | -2.04 |
| Weighted Average Shares Outstanding | 170.2 | 118.6 | 111.3 |
| Diluted Weighted Average Shares Outstanding | 170.2 | 118.6 | 111.3 |
